Related Experiment Video
Updated: Apr 27, 2026
04:52
A Modified Technique for Transverse Aortic Constriction in Mice
Published on: August 18, 2022
5.3K
[Heart failure - can be treated by affecting cardiac metabolism?]
Vnitrni Lekarstvi
|July 1, 2014
Summary
Chronic heart failure stems from the heart lacking sufficient energy or proper fuel utilization. Understanding cardiac energy metabolism and metabolic dysfunction offers potential therapeutic targets for heart failure treatment.
Area of Science:
- Cardiology
- Biochemistry
- Metabolic Medicine
Background:
- Chronic heart failure (CHF) is a widespread condition with significant mortality and morbidity.
- The multifactorial etiology of CHF often involves impaired cardiac energy production or utilization.
- Cardiac function relies on efficient substrate utilization, oxidative phosphorylation, and adenosine triphosphate (ATP) management.
Purpose of the Study:
- To elucidate the intricate functions of heart metabolism.
- To delineate the contribution of metabolic dysfunction to the pathogenesis of heart failure.
- To explore the potential of targeting cardiac metabolism as a therapeutic strategy for CHF.
Main Methods:
- Review of existing literature on cardiac energy metabolism.
- Analysis of the role of substrate utilization and ATP pathways in heart failure.
- Discussion of pharmacological interventions affecting heart metabolism.
Main Results:
- Heart failure is characterized by a "fuel" deficit or impaired fuel utilization within the cardiac muscle.
- Dysfunctional cardiac metabolism, including substrate supply and ATP turnover, is a key contributor to heart failure progression.
- Specific metabolic pathways are implicated in the pathophysiology of CHF.
Conclusions:
- Understanding cardiac metabolic pathways is crucial for comprehending heart failure.
- Metabolic dysfunction is a significant factor in the development and progression of chronic heart failure.
- Modulating heart metabolism presents a promising avenue for novel CHF therapies.
Related Concept Videos
01:30Heart Failure V: Medical Management
621
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
621
01:29Cardiomyopathy V: Interprofessional Care
750
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.7K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.7K
01:22Heart Failure Drugs: β-Blockers
2.6K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.6K
01:30Heart Failure VII: Nursing Interventions
783
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
783
01:26Heart Failure Drugs: Inotropic Agents
1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K